Investors Snag AQST 41.3% Cheaper Than Its Secondary Stock Offering
June 20, 2024 at 10:20 AM EDT
Looking back to 93 days ago, Aquestive Therapeutics Inc (AQST) priced a 16,666,667 share secondary stock offering at $4.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..